SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001561743-17-000019
Filing Date
2017-05-24
Accepted
2017-05-24 16:23:38
Documents
4
Period of Report
2017-05-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K a8-k2017shareholderrightsp.htm 8-K 52815
2 CERTIFICATE OF DESIGNATION exhibit31-certificateofdes.htm EX-3.1 42467
3 RIGHTS AGREEMENT exhibit41-kindredrightsagr.htm EX-4.1 440037
4 EMPLOYMENT AGREEMENT AMENDMENT exhibit101-amendmentno3toe.htm EX-10.1 8988
  Complete submission text file 0001561743-17-000019.txt   545608
Mailing Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010
Business Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010 650-701-7901
Kindred Biosciences, Inc. (Filer) CIK: 0001561743 (see all company filings)

IRS No.: 461160142 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36225 | Film No.: 17866964
SIC: 2834 Pharmaceutical Preparations